Back to search

United States· US:42291-047_484c12cb-6b66-1ca6-e063-6394a90a7cfb

Chloroquine Phosphate

A chloroquine product containing chloroquine phosphate, registered in United States by AvKARE. The same ATC class is registered in 7 of our 19 countries.

ATC P01BA01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedChloroquine PhosphateATCP01BA01REGISTER NO.US:42291-047_484c12cb…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Chloroquine is registered in 7 of 19 countries.

Countries holding a registration under ATC P01BA01 (chloroquine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose

Chloroquine · ATC P01BA01

7 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Netherlands
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of chloroquine costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Chloroquine · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • FR France$1.22
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
CHLOROQUINE PHOSPHATE
Manufacturer
AvKARE
Country
United States (US)
ATC code
P01BA01
ATC class
Chloroquine
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    42291-047-25
  • ndc11
    4229104725
    25 TABLET in 1 BOTTLE (42291-047-25)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

557 interactions on record for chloroquine.

Graded by severity as the source publishes them — 221 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Chloroquine · interactions on record

557 records

  • 221 severe
  • 306 moderate
  • 14 minor
  • 16 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chloroquine in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chloroquine products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Cyprus · Chloroquine Phosphate Remedica
  • Spain · Resochín
  • United Kingdom (Northern Ireland) · Avloclor, Chloroquine Phosphate Bristol Laboratories
  • Greece · Unikinon
  • Hungary · Delagil
  • Netherlands · A-Cq 100
  • Portugal · Cloroquina Labesfal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5da7e56e-a91c-4a94-b4b7-ad3341c987c2
GET /v1/drugs/5da7e56e-a91c-4a94-b4b7-ad3341c987c2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "500",
  "substance": "CHLOROQUINE PHOSPHATE",
  "productndc": "42291-047",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA040516",
  "marketing_category": "ANDA"
}

See everything about chloroquine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.